Wilson's Disease Vitamin B6

## Mechanism of Pyridoxine (Vitamin B6) Depletion by Penicillamine Penicillamine acts as a **pyridoxine antagonist** by chemically combining with the aldehyde moiety of vitamin B6, thereby disrupting its metabolic function [7]. This interaction increases the physiological requirement for pyridoxine during therapy. ## Clinical Rationale for Supplementation ### Mandatory Supplementation in Wilson's Disease and Cystinuria According to the prescribing information for penicillamine (Cuprimine, Depen, Penicillamine Capsules), patients with **Wilson's disease or cystinuria must be given 25 mg/day of pyridoxine** during therapy [1][2][4][5]. The rationale is that penicillamine increases the requirement for this vitamin, and these patients are at particular risk due to their concurrent dietary restrictions. ### Dietary Restriction Context Patients with Wilson's disease are placed on a **low-copper diet** (≤1-2 mg copper/day), which excludes foods such as chocolate, nuts, shellfish, mushrooms, liver, molasses, broccoli, and copper-enriched cereals [4][5][8]. This restricted diet may further compromise pyridoxine intake, compounding the drug-induced depletion. ### Additional At-Risk Populations - **Rheumatoid arthritis patients** with impaired nutrition should also receive a daily pyridoxine supplement [1][2][4][5] - **Pregnant or breastfeeding women** and those with **malabsorption** have increased baseline requirements [6] ## Dosing Recommendations | Source | Recommended Dose | Notes | |--------|-----------------|-------| | Drug Labels (Cuprimine, Depen, Penicillamine Capsules) | **25 mg/day** | Standard for Wilson's disease and cystinuria [1][2][4][5] | | BASL Guideline (2022) | **50 mg once daily** | For patients requiring >40 mg/kg/day penicillamine or those at increased deficiency risk [6] | | Harrison's Neurology | **30 mg/day** | General treatment dose for pyridoxine deficiency [7] | ## Clinical Consequences of Deficiency Pyridoxine deficiency from penicillamine therapy can manifest as: - **Hypogeusia** (blunted or diminished taste perception) — occurs in some patients, may last 2-3 months or more, and can progress to total loss of taste; however, it is usually self-limited despite continued penicillamine treatment [1][2][4][5] - **Subacute length-dependent axonal neuropathy** — a recognized consequence of pyridoxine deficiency [7] ## Safety Consideration Overzealous pyridoxine supplementation should be avoided, as **high doses of pyridoxine can cause a toxic sensory neuronopathy** [7]. The standard 25 mg/day dose recommended in the drug labels is well within the safe range. ## Conclusion Concurrent pyridoxine (25 mg/day) is mandatory during penicillamine therapy for Wilson's disease because penicillamine acts as a pyridoxine antagonist, increasing vitamin B6 requirements, and the concurrent low-copper diet may further limit dietary intake. This supplementation prevents hypogeusia and neuropathy while avoiding the toxicity associated with excessive dosing. --- *This information is derived from drug labels and clinical literature. Individual patient management should consider specific clinical circumstances and verify against current prescribing information.*